Administration of nonanticoagulant heparin inhibits the loss of glycosaminoglycans from xenogeneic cardiac grafts and prolongs graft survival

Transplant Proc. 1993 Feb;25(1 Pt 1):382.
No abstract available

MeSH terms

  • Animals
  • Cells, Cultured
  • Endothelium, Vascular / drug effects
  • Endothelium, Vascular / metabolism*
  • Glycosaminoglycans / metabolism*
  • Graft Rejection / prevention & control
  • Graft Survival / physiology*
  • Guinea Pigs
  • Heart Transplantation / physiology*
  • Heparin / pharmacology*
  • Heparitin Sulfate / metabolism
  • Humans
  • Kinetics
  • Rats
  • Rats, Inbred Lew
  • Swine
  • Transplantation, Heterologous / physiology*
  • Transplantation, Isogeneic / physiology

Substances

  • Glycosaminoglycans
  • Heparin
  • Heparitin Sulfate